ТРАНСПЛАНТАЦИЯ ПЕЧЕНИ У ДЕТЕЙ С БОЛЕЗНЯМИ НАКОПЛЕНИЯ ГЛИКОГЕНА: ОЦЕНКА РИСКА И НЕОБХОДИМОСТИ ЕЕ ПРОВЕДЕНИЯ
https://doi.org/10.15825/1995-1191-2013-1-67-74
Аннотация
Болезни накопления гликогена I, III, IV типа являются врожденными заболеваниями, которые обычно ведут к тяжелому поражению печени. Трансплантация печени является терапией выбора при данных патологиях. В то время как пересадка печени нивелирует первичный дефект фермента в печени, внепе- ченочные проявления гликогенозов порой осложняют посттрансплантационный период. В статье опи- саны данные англоязычной литературы, согласно которой 42 детям до 18 лет по поводу осложнений гликогенозов были проведены трансплантации печени (18 пациентам – в связи с гликогенозом Ia типа, шестерым – Ib, одному ребенку – III типа, 17 пациентам – по поводу гликогеноза IV типа). В работе представлено описание трансплантации печени ребенку по поводу гликогеноза Ia типа, проведен анализ посттрансплантационного периода жизни реципиента.
Об авторах
C. В. ГотьеО. М. Цирульникова
Д. С. Мнацаканян
И. М. Ильинский
Н. П. Можейко
Список литературы
1. Adachi M., Shinkai M., Ohhama Y. et al. Improved neu- trophil function in a glycogen storage disease type Ib patient after liver transplantation // Eur. J. Pediatr. 2004. Vol. 5. P. 202–206.
2. Alshak N.S., Cocjin J., Podesta L. et al. Hepatocellular
3. adenoma in glycogen storage disease type IV // Arch. Pa-
4. thol. Lab. Med. 1994. Vol. 118. P. 88–91.
5. Arikan C., Kilic M., Nart D. et al. Hepatocellular car-
6. cinoma in children and effect of living-donor liver transplantation on outcome // Pediatr. Transplant. 2006. Vol. 10. P. 42–47.
7. Belingheri M., Ghio L., Sala A. et al. Combined liver- kidney transplantation in glycogen storage disese Ia: A case beyond the guidelines // Liver Transpl. 2007. Vol. 13. P. 762–764.
8. Bhattacharaya N., Heaton N., Rela M. et al. The benefits of liver transplantation in glycogenosis type Ib // J. Inhe- rit Metab. Dis. 2004. Vol. 27. P. 539–540.
9. Bianchi L. Glycogen storage disease I and hepatocellular tumours // Eur. J. Pediatr. 1993. Vol. 152 (1). P. S63–S70.
10. BrunoC.,VanDiggelenO.P.,CassandriniD.etal.Clini- cal and genetic heterogeneity of brancing enzyme defici- ency (glycogenolis type IV) // Neurology. 2004. Vol. 63.
11. P. 1053–1058.
12. Chen Y.-T., Burchell A. Glycogen storage diseases //
13. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. eds. The Metabolic Basis of Inherited Disease. 8th edition. New York: McGraw-Hill. P. 1521–1551.
14. Choi B.Y., Nouyen M.H. The diagnosis and management of benign hepatic tumors // J. Clin. Gastroenterol. 2005. Vol. 39. P. 401–412.
15. Coire C.I., Qizilbash A.H., Castelli M.F. Hepatic adeno- mata in type Ia glycogen storage disease // Arch. Pathol. Lab. Med. 1987. Vol. 111. P. 166–169.
16. Czauderna P. Adult type vs. Childhood hepatocellular carcinoma – are they the same or different lesions? Di- ology, natural history, prognosis, and treatment // Med. Pediatr. Oncol. 2002. Vol. 39. P. 519–523.
17. De La Blanchardiere A., Vayssier C., Duboc D. et al. Severe cardiomyopathy revealing amylopectinosis. Two cases in adolescents from the same family // Presse Med. 1994. Vol. 23. P. 1124–1127 [French].
18. Demo E., Frush D., Gottfried M. et al. Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? // J. Hepatol. 2007. Vol. 46. P. 492–498.
19. Dhawan A., Tan K.C., Portmann B. et al. Glycogenosis type IV: Liver transplant at 12 years // Arch. Dis. Child. 1994. Vol. 71. P. 450–451.
20. Ewert R., Gulijew A., Wensel R. et al. Glycogenosis type IV as a seldom cause of a cardiomyopathy – report about a succesful heart transplantation // Z. Kardiol. 1999. Vol. 88. P. 850–856 [German].
21. Faivre L., Houssin D., Valayer J. et al. Lomg-term out- come of liver transplantation in patients with glycogen storage disease type Ia // J. Inherit. Metab. Dis. 1999. Vol. 22. P. 723–732.
22. Franco L.M., Krishnamurthy V., Bali D. et al. Hepa- tocellular carcinoma in glycogen storage disease Ia: A case series // J. Inherit. Metab. Dis. 2005. Vol. 28. P. 153–162.
23. Gitzelmann R., Bosshard N.U. Defective neutrophil and monocyte functions in glycogen storage disease type Ib:
24. A literature review // Eur. J. Pediatr. 1993. Vol. 152 (1).
25. P. S33–S38.
26. Grazioli L., Federle M.P., Brancatelli G. et al. Hepatic
27. Adenomas: Imaging and pathologic findings // Radiogra-
28. phics. 2001. Vol. 21. P. 877–892.
29. Haagsma E.B., Smit G.P., Niezen-Koning K.E. et al. Type
30. IIIb glycogen storage disease associated with end-srage cirrhosis and hepatocellular carcinoma. The Liver Trans- plant Group // Hepatology. 1997. Vol. 25. P. 537–540.
31. Koestinger A., Gillet M., Chiolero R. et al. Effect of liver transplantation on hepatic glucose metabolism in a pati- ent with type I glycogen storage disease // Transplantati- on. 2000. Vol. 69. P. 2205–2207.
32. Kudo M. Hepatocellular adenoma in type IA glycogen storage disease // J. Gastroenterol. 2001. Vol. 36. P. 65–66.
33. Labrune P. Glycogen storage disease type I: Indications for liver and/or kidney transplantation // Eur. J. Pediatr.
34. Vol. 161 (1). P. S53–S55.
35. Labrune P., Trioche P., Duvaltier I. et al. Hepatocel-
36. lular adenomas in glycogen storage disease type I and III: A series of 43 patients and review of the literature // J. Pediatr. Gastroenterol. Nutr. 1997. Vol. 24. P. 276–279.
37. Lachaux A., Boillot T., Stamm D. et al. Treatment with lenograstim (glycolysated recombinant human granu- locyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type Ib // J. Pediatr. 1993. Vol. 123. P. 1005–1008.
38. Lee P.J. Glycogen storage disease type I: Pathophysiolo- gy of liver adenomas // Eur. J. Pediatr. 2002. Vol. 161 (1). P. S46–S49.
39. Lee P.J, Muiessan P., Heaton N. Successful pregnancy after combined renal-hepatic transplantation in glycogen storage disease type Ia // J. Inherit. Metab. Dis. 2004. Vol. 27. P. 537–538.
40. Lerut J.P., Ciccarelli O., Sempoux C. et al. Glycogenosis storage type I diseases and evolutive adenomatosis: An indication for liver transplantation // Transpl. Int. 2003. Vol. 16. P. 879–884 [E-pub August 7, 2003].
41. Limmer J., Fleig W.E., Leupold D. et al. Hepatocellular carcinoma in type I glycogen storage disease // Hepato- logy. 1988. Vol. 8. P. 531–537.
42. Liu P.P., De Villa V.H., Chen Y.S. et al. Outcome of living donor transplantation for glycogen storage disease // Transplant. Proc. 2003. Vol. 35. P. 366–368.
43. Malatack J.J., Finegold D.N., Iwatsuki S. et al. Liver transplantation for type I glycogen storage disease // Lancet. 1983. Vol. 1. P. 1073–1075.
44. Martin S.R., Atkison P., Anand R. et al. Studies for Pedi- atric Liver Transplantation 2002: Patient and graft sur- vival and rejection in pediatric recipients of a first liver transplant in the United States and Canada // Pediatr. Transplant. 2004. Vol. 8. P. 273–283.
45. Martin A.P., Bartels M., Schreiber S. et al. Successful staged kidney and liver transplantation for glycogen sto- rage disease type Ib: A case report // Transplant. Proc. 2006. Vol. 38. P. 3615–3619.
46. Martinez-Ibanez V., Margarit C., Tormo R. et al. Liver transplantation in metabolic diseases. Report of five pe- diatric cases // Transplant. Proc. 1987. Vol. 19. P. 3803– 3804.
47. Matern D., Starlz T.E., Arnaout W. et al. Liver transplan- tation for glycogen storage diseases types I, III, IV // Eur. J. Pediatr. 1999. 158 (1). P. S43–S48.
48. Morioka D., Kasahara M., Takada Y. et al. Living do- nor lever transplantation for pediatric patients with in- heritable metabolic disorders // Am. J. Transplant. 2005. Vol. 5. P. 2754–2763.
49. Moses S.W., Parvari R. The variable presentations of glycogen storage disease type IV: A review of clinical, enzymatic and molecular studies // Curr. Mol. Med. 2002. Vol. 2. P. 177–188.
50. Muraca M., Burlina A.B. Liver and liver cell transplan- tation for glycogen storage disease type IA // Acta Gast- roenterol. Belg. 2005. Vol. 68. P. 469–472.
51. Parker P., Burr I., Slonim A. et al. Regression of jepatic adenomas in type Ia glycogen storage disease with dieta- ry therapy // Gastroenterology. 1981. Vol. 81. P. 534–536.
52. Poe R., Snover D.C. Adenomas in glycogen storage disease type Ia. Two cases with unusual histologic fea- tures // Am. J. Surg. Pathol. 1988. 12. P. 477–483.
53. Rake J.P., Visser G., Labrune P. et al. Glycogen storage disease type I: Diagnosis, management, clinical course and outcome. Results of the European Study on Glyco- gen Storage Disease Type I (ESGSD I) // Eur. J. Pediatr. 2002. Vol. 161 (1). P. S46–S49.
54. Rake J.P., Visser G., Labrune P. et al. Guidelines for ma- nagement of glycogen storage disease type I – European Study on Glycogen Storage Disease Type I (ESGSD I) // Eur. J. Pediatr. 2002. Vol. 161 (1). P. S112–S119.
55. Reid C.J., Hebert D. Acute renal failure complicating liver transplantation in twin sisters with glycogen sto-
56. rage disease type Ia // Transplant. Proc. 1996. Vol. 28.
57. P. 3629–3631.
58. Selby R., Starlz T.E., Yunis E. et al. Liver transplantation
59. for type I and type IV glycogen storage disease // Eur. J.
60. Pediatr. 1993. Vol. 152 (1). P. S71–S76.
61. Shirasawa Y., Nomura T., Yoshida A. et al. Liver trans-
62. plantation-associated hypercalcemia followed by acute re-
63. nal dysfunction // Intern. Med. 2004. Vol. 43. P. 802–806.
64. Starlz T.E., Demetris A.J., Trucco M. et al. Chimerism after liver transplantation for type IV glycogen storage disease and type I Gaucher’s disease // N. Engl. J. Med.
65. Vol. 328. P. 745–749.
66. Sokal E.M., Lopez-Silvarrey A., Buts J.P. et al. Orthoto-
67. pic liver transplantation for type I glycogenosis unres- ponsive for medical therapy // J. Pediatr. Gastroenterol. Nutr. 1993. Vol. 16. P. 465–467.
68. Sokal E.M., Van Hoof F., Alberti D. et al. Progressive cardiac failure following orthotopic liver transplanta- tion for type IV glycogenosis // Eur. J. Pediatr. 1992. Vol. 151. P. 200–203.
69. Superina R.A., Pearl R.H., Roberts E.A. et al. Liver transplantation in children. The initial Toronto experi- ence // J. Pediatr. Surg. 1989. Vol. 24. P. 1013–1019.
70. Weinstein D.A., Roy C.N., Fleming M.D. et al. Inappro- priate expression of hepcidin is associated with iron re- fractory anemia: Inplications for the anemia of chronic disease // Blood. 2002. Vol. 100. P. 3776–3781.
71. Wolfsdorf J.I., Holm I.A., Weinstein D.A. Glycogen sto- rage diseases. Phenotypic, genetic, and biochemical characteristics, and therapy // Endocrinol. Metab. Clin. North Am. 1999. Vol. 28. P. 801–823.
Рецензия
Для цитирования:
Готье C.В., Цирульникова О.М., Мнацаканян Д.С., Ильинский И.М., Можейко Н.П. ТРАНСПЛАНТАЦИЯ ПЕЧЕНИ У ДЕТЕЙ С БОЛЕЗНЯМИ НАКОПЛЕНИЯ ГЛИКОГЕНА: ОЦЕНКА РИСКА И НЕОБХОДИМОСТИ ЕЕ ПРОВЕДЕНИЯ. Вестник трансплантологии и искусственных органов. 2013;15(1):67-74. https://doi.org/10.15825/1995-1191-2013-1-67-74
For citation:
Gautier S.V., Tsirulnikova O.M., Mnatsakanyan D.S., Ilyinsky I.M., Mozheiko N.P. LIVER TRANSPLANTATION IN CHILDREN WITH GLYCOGEN STORAGE DISEASES: RISK ASSESSMENT AND NECESSITY OF THIS PROCEDURE. Russian Journal of Transplantology and Artificial Organs. 2013;15(1):67-74. (In Russ.) https://doi.org/10.15825/1995-1191-2013-1-67-74